Table 1.
Basic demographics and role in Phase 1 and Phase 2. The data reported here reflects those individuals who participated in year 1 in the following: (1) interviews (clinical personnel), (2) focus groups (experts and test patients), and (3) the testing with both clinical personnel and test patients.
| Stage, position | Demographics | |||
| Gender | Age (years) | Race | ||
| Interviewsa | ||||
|
|
PCPb | F | 38 | Asian |
| PCP | F | 31 | White | |
| PCP | F | 31 | White | |
| PCP | F | 54 | White | |
| PCP | F | 49 | Asian | |
| PCP | F | 62 | White | |
| Staff registered nurse | F | 57 | African American | |
| Staff registered nurse | F | 38 | White | |
| Staff MAc | F | 43 | White | |
| Staff MA | F | 36 | African American | |
| Staff MA | F | 33 | White | |
| Expert focus group | ||||
|
|
Assistant professor | F | 42 | White |
| PhD researcher | M | 42 | White | |
| Professor, clinical pharmacist specialist | F | 58 | White | |
| Nicotine expert | M | (Missing) | African American | |
| Professor | F | 47 | White | |
| Director, addiction division, Veterans Affairs | M | 49 | White | |
| Tobacco treatment specialist (retired) | F | 71 | White | |
| Coordinator/lung cancer screening | F | 58 | White | |
| Case manager/lung cancer screening | F | 43 | White | |
| Patient focus group (smoker) | ||||
|
|
Yes | F | 69 | White |
| Yes | M | 66 | White | |
| Yes | M | 39 | White | |
| Yes | F | 29 | White | |
| Yes | F | 33 | White | |
| App testing with clinical personnel | ||||
|
|
PCP | F | 30 | African American |
| PCP | F | 54 | White | |
| PCP | M | 40 | White | |
| Staff registered nurse | F | 57 | White | |
| Staff registered nurse | F | 38 | White | |
| App testing with patients | ||||
|
|
—d | M | 30 | White |
| — | F | 52 | White | |
| — | M | 66 | White | |
| — | F | 59 | White | |
| — | M | 29 | White | |
| — | M | 47 | White | |
| — | M | 55 | White | |
aInterviews are from clinical personnel from 3 clinical sites.
bPCP: primary care physician.
cMA: medical assistant.
d—: not applicable.